Patent details

EP2736491 Title: BEPOTASTINE COMPOSITIONS

Basic Information

Publication number:
EP2736491
PCT Application Number:
US2012020028
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127324556
PCT Publication Number:
WO2012094283
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BEPOTASTINE COMPOSITIONS
French Title of Invention:
COMPOSITIONS DE BÉPOSTATINE
German Title of Invention:
BEPOTASTIN-ZUSAMMENSETZUNG
SPC Number:

Dates

Filing date:
03/01/2012
Grant date:
05/04/2017
EP Publication Date:
04/06/2014
PCT Publication Date:
12/07/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/04/2017
EP B1 Publication Date:
05/04/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/01/2018
Expiration date:
03/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/04/2017
 
 

Name:
Bausch & Lomb Incorporated
Address:
1400 North Goodman Street, Area 62, Rochester, NY 14609, United States (US)

Name:
Mitsubishi Tanabe Pharma Corporation
Address:
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)

Inventor

1

Name:
BAKLAYAN, George
Address:
United States (US)

2

Name:
PADILLA, Angel
Address:
United States (US)

Priority

Priority Number:
201161429721 P
Priority Date:
04/01/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/10; A61K 9/12; A61K 31/444; A61K 45/06; A61K 47/38; A61P 11/00; A61P 11/02; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
201714
Publication date:
05/04/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/05/2018 Outgoing Correspondence 1